Cases & Deals

Acorda Therapeutics develops patent portfolio relating to Ampyra®

Clients Acorda Therapeutics, Inc.

Jones Day represents Acorda Therapeutics, Inc. in patent prosecution and portfolio development relating to Ampyra®.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.